AIHTA - Publications - Search - Horizon Scanning in Oncology 23rd Prioritisation – 2nd quarter 2015

Rothschedl, E. and Nachtnebel, A. (2015): Horizon Scanning in Oncology 23rd Prioritisation – 2nd quarter 2015. HSO: 23rd Prioritisation.

[thumbnail of HSO_23rd_Prioritisation.pdf]
PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader

For the 23rd prioritisation (June 2015), 10 drugs were filtered out of 170 identified and were sent to prioritisation. Of these, 4 drugs were ranked as "highly relevant" by the expert panel, 5 as "relevant" and 1 as "not relevant". For "highly relevant" drugs, further information including, for example, abstracts of phase III studies and licensing status is contained in this document.

Item Type:DSD: Horizon Scanning in Oncology
Subjects:WB Practice of medicine > WB 300-962 Therapeutics
QZ Pathology > QZ 200-380 Neoplasms.Cysts
QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology
Series Name:HSO: 23rd Prioritisation
Deposited on:17 Aug 2015 10:10
Last Modified:15 Jul 2020 17:53

Repository Staff Only: item control page